IFNG and infection: In this setting, the specific IFNγ T cell responses against the spike and RBD were significantly higher in all vaccine recipients at 9 months (T3) compared to pre-pandemic healthy donors, with no difference between previously infected and infection-naïve subjects (Figure 3A).